Technor Inc.: Is This Shining Star Rising Or Falling?

LIVERMORE, CALIF.—It seemed like a great idea at the time: In the spring of 1987, chemist Bob Peny, armed with a quiet resolve and the patent to a pollution-reducing process he had discovered while a researcher at Sandia National Laboratory’s Combustion Research Facility (CRF) in Livermore, left a secure, challenging, and well-paying job to start his own company, Technor Inc. Launched with a Department of Energy Small Business and Innovation Research grant, the startup seemed de

Written byBruce Fellman
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

LIVERMORE, CALIF.—It seemed like a great idea at the time: In the spring of 1987, chemist Bob Peny, armed with a quiet resolve and the patent to a pollution-reducing process he had discovered while a researcher at Sandia National Laboratory’s Combustion Research Facility (CRF) in Livermore, left a secure, challenging, and well-paying job to start his own company, Technor Inc.

Launched with a Department of Energy Small Business and Innovation Research grant, the startup seemed destined to be a shining star in the federal government’s technology transfer heavens. Even the Secretary of Energy publicly acclaimed the “exciting potential” of Perry’s new technology. What better weapons could an enterprising scientist hope to be armed with upon sallying forth into the venture capital jungle?

So far, however, Bob Perry’s weapons haven’t been enough. His promising technology has yet to help anyone breathe easier—or to make him a millionaire. It will be at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery